Category: Delatestryl

  • Jatenzo – An Oral Testosterone for Hypogonadism

    Date:  June 28, 2021 Issue #:  1627 Summary:  An oral formulation of testosterone undecanoate (Jatenzo – Clarus) has been approved by the FDA for treatment of adult men with conditions associated with a deficiency of endogenous testosterone, such as Klinefelter syndrome, orchiectomy, toxic damage from chemotherapy or alcohol, or pituitary-hypothalamic injury from tumors, trauma, or […]